Today: 17 June 2026

Mateusz Kaczmarek

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Starbucks (SBUX) Brewing Gains? CEO’s Shake-Up & $5B China Deal Fuel Stock Rally

Starbucks (SBUX) Brewing Gains? CEO’s Shake-Up & $5B China Deal Fuel Stock Rally

Starbucks stock closed at $85.36 on Oct. 17, up nearly 9% for the week but still down about 10% year-over-year. CEO Brian Niccol is leading a $1 billion turnaround, closing several hundred North American stores and cutting 900 corporate jobs. Q3 FY2025 profit fell 47% year-over-year, missing estimates. Labor tensions are rising as unionized baristas protest closures, while Starbucks explores a partial sale of its China business.
18 October 2025
Ford (F) Stock Plunges After Supplier Fire and EV Slump — Can It Rebound?

Ford (F) Stock Plunges After Supplier Fire and EV Slump — Can It Rebound?

Ford shares closed at $11.92 on Oct. 17, 2025, up about 25% year-to-date despite a sharp drop after a key supplier’s plant fire and major recalls. Q3 U.S. vehicle sales rose 8.2% to 545,522 units, driven by strong pickup and SUV demand. Ford’s EV business posted a $1.3 billion Q2 loss as U.S. EV sales fell 31%. The company secured a four-year UAW contract and faces new tariffs on imported trucks.
Exxon Mobil (XOM) Stock on Rollercoaster Ride – Oil Crashes & Big News Spark Wild Market Debate

Exxon Mobil (XOM) Stock on Rollercoaster Ride – Oil Crashes & Big News Spark Wild Market Debate

Exxon Mobil closed at $112.24 on Oct. 17, near the midpoint of its 52-week range. Wells Fargo upgraded the stock to “Strong Buy” as analysts remain split on price targets. U.S. crude prices slid to five-year lows near $57/barrel, pressuring energy stocks. Exxon announced a preliminary deal to develop Iraq’s Majnoon oilfield and plans to cut about 2,000 jobs globally.
18 October 2025
GRAIL (GRAL) Stock Skyrockets on Samsung’s $110M Bet and Cancer-Screening Breakthrough

GRAIL (GRAL) Stock Skyrockets on Samsung’s $110M Bet and Cancer-Screening Breakthrough

GRAIL shares surged 13–14% to a record $85.35 on Oct. 16 after announcing a $110 million equity deal with Samsung and plans to bring its Galleri cancer test to Asia. New trial data at ESMO showed Galleri doubled early cancer detection versus routine screening. Despite gains, most analysts rate GRAL a “Hold” with an average target below current prices. Q2 revenue rose 11% to $35.5M; net loss narrowed to $114M.
Disney Stock Could Soar? Analysts Pin 20% Upside on Streaming Shake-Up and Park Growth

Disney Stock Could Soar? Analysts Pin 20% Upside on Streaming Shake-Up and Park Growth

Disney shares closed at $110.70 on Oct. 17, up 1.4% for the week and nearly flat year-to-date. In August, Disney beat Q3 earnings estimates and raised full-year guidance, with parks income up 13% and streaming turning profitable. Disney+ and Hulu prices rise Oct. 21 as the company pushes a global Hulu rebrand and prepares a bundled “super app” for 2026. Wall Street rates DIS a “Moderate Buy” with a $133 average target.
18 October 2025
Apple Stock Could Explode After New AI Chip Launch and iPhone 17 “Supercycle,” Analysts Say

Apple Stock Could Explode After New AI Chip Launch and iPhone 17 “Supercycle,” Analysts Say

Apple closed at $252.29 on Oct. 17, 2025, just below its all-time intraday high near $260. Year-to-date, AAPL is up about 2%, trailing Nvidia and Microsoft. iPhone 17 sales are running 10–15% ahead of last year, and new M5-chip devices launched mid-October. COO Jeff Williams will retire by year-end, with John Ternus positioned as Tim Cook’s likely successor.
GE Aerospace Stock Rockets as Rally Continues – Q3 Earnings, Contracts, and Analyst Targets in Focus

GE Aerospace Stock Rockets as Rally Continues – Q3 Earnings, Contracts, and Analyst Targets in Focus

GE Aerospace (NYSE: GE) closed at $300.14 on Oct 17, up 78% year-to-date, near its 52-week high of $307.25. Q3 earnings are due Oct 21, with analysts expecting $1.45 EPS on $10.3 billion sales, up 27% from last year. CEO Larry Culp’s contract was extended through 2027, and GE recently secured a $5 billion USAF F110 engine order. The quarterly dividend stands at $0.36 per share.
18 October 2025
IBM Stock Rockets 28%: AI Boom, Quantum Breakthroughs & Big Deals Spark Rally

IBM Stock Rockets 28%: AI Boom, Quantum Breakthroughs & Big Deals Spark Rally

IBM closed at $281.28 on Oct. 17, up 28% year-to-date and near multi-year highs. The company announced new AI partnerships with Bharti Airtel, AMD, and Anthropic, and agreed to acquire SAP consultant Cognitus. IBM will report Q3 results on Oct. 22; analysts expect EPS around $3.00 and see limited upside unless AI/cloud growth accelerates. The stock yields 2.3% with a 45x P/E ratio.
Psychedelic Biotech Rally: Atai Life Sciences Stock Soars 18% on FDA Breakthrough and $130M Fundraise

Psychedelic Biotech Rally: Atai Life Sciences Stock Soars 18% on FDA Breakthrough and $130M Fundraise

Atai Life Sciences shares surged 18% to close near $6.45 on Oct. 17, 2025, after the FDA granted Breakthrough Therapy status to its experimental depression nasal spray BPL-003. The company raised $130 million in a public offering at $5.48 per share. Analysts issued strong Buy ratings with targets up to $15. ARK Invest disclosed buying about 250,000 shares.
18 October 2025
Cisco Stock Surges Near 52-Week High on AI Momentum – What’s Next for CSCO?

Cisco Stock Surges Near 52-Week High on AI Momentum – What’s Next for CSCO?

Cisco Systems shares traded near $69–$70 on Oct. 17, 2025, close to a 52-week high and up about 30% over 12 months. The company reported Q4 earnings of $0.99 per share on $14.67 billion revenue, beating forecasts, and guided for 5–6% revenue growth in FY2026. Cisco launched new AI-focused products in October, with early orders from Microsoft and Alibaba. Market cap stands at roughly $270 billion.
New Era Energy (NUAI) Stock Skyrockets on AI Data Center Pivot – Can the Rally Last?

New Era Energy (NUAI) Stock Skyrockets on AI Data Center Pivot – Can the Rally Last?

New Era Energy & Digital (NASDAQ: NUAI) closed at $4.55 on Oct. 17, up 44% for the day and 186% in two weeks, after announcing progress on its Texas AI data center project. The company regained Nasdaq compliance, ended plans for a new share sale, and now claims to be sufficiently funded. Market cap stands near $129 million. New Era remains pre-revenue, with heavy trading volume and ongoing volatility.
MindMed Stock Rockets on Breakthrough LSD Anxiety Data – Analysts Eye 100% Upside

MindMed Stock Rockets on Breakthrough LSD Anxiety Data – Analysts Eye 100% Upside

MindMed shares hit a 52-week high of $13.09 on Oct. 14, up 68% year-to-date, after its LSD-derived drug MM120 showed 48% remission in a Phase 2b anxiety trial and received FDA Breakthrough Therapy status. The company holds $237.9 million in cash and is running three Phase 3 studies, with topline results due in 2026. Most analysts rate MNMD a “Moderate Buy” with an average 12-month target near $28.
18 October 2025
Virgin Galactic (SPCE) Stock Rockets 40% Then Reverses – What’s Fueling the Space Tourism Frenzy?

Virgin Galactic (SPCE) Stock Rockets 40% Then Reverses – What’s Fueling the Space Tourism Frenzy?

Virgin Galactic shares fell 7.9% to $4.08 on Oct. 18 after spiking over 40% earlier in the month, driven by heavy trading and high short interest. Q2 2025 revenue dropped to $0.4 million, with a net loss of $67 million. The company holds $508 million in cash, targeting late 2026 for its new Delta Class spaceplane’s first flight. Wall Street consensus is Neutral, with price targets recently cut to $2–$2.50 by some analysts.
18 October 2025
Sellas Life Sciences (SLS) Stock Rallies on Promising Leukemia Data – Analysts Eye Triple-Digit Upside

Sellas Life Sciences (SLS) Stock Rallies on Promising Leukemia Data – Analysts Eye Triple-Digit Upside

Sellas Life Sciences (NASDAQ:SLS) closed near $2.14 on Oct. 17, up about 100% year-to-date, with trading volatility and a 761% surge in call options on Oct. 14. Its GPS immunotherapy remains in Phase 3, while SLS009 showed strong preclinical results and a 44% response rate in Phase 2 AML data. Sellas raised $23.6M in September and had $25.3M cash at June 30. Analyst targets range from $6–7, with short interest at 18%.
Rani Therapeutics (RANI) Stock Surges 150% on $1B+ Chugai Collaboration – Analysts Weigh In

Rani Therapeutics (RANI) Stock Surges 150% on $1B+ Chugai Collaboration – Analysts Weigh In

Rani Therapeutics shares surged over 150% on Oct. 17, 2025, after announcing a collaboration and license deal with Chugai Pharmaceutical worth up to $1.085 billion. The company also raised $60.3 million in PIPE financing, stating it now has funding into 2028. Trading volume spiked to 70 million shares, up from a 300,000 average. Analyst opinions remain split on the stock’s outlook.
Beyond Meat Stock Implodes: 60% Crash After Shocking Debt-For-Equity Swap

Beyond Meat Stock Implodes: 60% Crash After Shocking Debt-For-Equity Swap

Beyond Meat shares plunged nearly 60% intraday on Oct. 13, 2025, closing at about $0.67 by Oct. 15—near record lows. The company swapped 96.9% of its 2027 convertible debt for $208.7 million in new notes and 316.15 million new shares, heavily diluting equity. Founder/CEO Ethan Brown and CFO Nandita Bakhshi resigned from the board. Analyst ratings remain strongly negative, with short interest at record highs.
18 October 2025
Liberty Energy (LBRT) Stock Surges 28% After Q3 Earnings – What’s Next?

Liberty Energy (LBRT) Stock Surges 28% After Q3 Earnings – What’s Next?

Liberty Energy shares surged 28% to $15.32 on Oct. 17 after Q3 results, rebounding from a prior close of $11.94. Revenue fell 17% to $947 million, with an adjusted EPS loss of $0.06, but GAAP net income reached $43 million due to one-time gains. Management raised the dividend 13%. Despite the rally, the stock remains well below last year’s $23.58 high.
Gilead Stock Skyrockets on Patent Win and Game-Changing HIV Therapies

Gilead Stock Skyrockets on Patent Win and Game-Changing HIV Therapies

Gilead shares closed near $123 on Oct. 17, 2025, up 4.2% and close to 52-week highs, after extending Biktarvy’s U.S. exclusivity to 2036 and securing a CDC endorsement for Yeztugo. Q2 earnings beat forecasts, prompting raised guidance and analyst upgrades. Gilead is set to present positive Phase 3 Trodelvy data at ESMO and is expanding cell therapy with a $350M Interius BioTherapeutics deal.
1 81 82 83 84 85 148

Stock Market Today

  • NSE Eyes Rs 5 Lakh Crore Valuation in Upcoming IPO Filing
    June 16, 2026, 11:28 PM EDT. The National Stock Exchange (NSE) plans to file its Draft Red Herring Prospectus (DRHP) today for a much-anticipated initial public offering (IPO). Sources indicate the offer size may represent about 5% of NSE's equity capital, exceeding the Securities and Exchange Board of India's (SEBI) minimum public float requirement of 2.5% for companies with valuations above Rs 10,000 crore. The exchange targets a valuation exceeding Rs 5 lakh crore, marking one of the largest IPOs in India's financial sector.

Latest articles

Dow Closes at Record in After-Hours as S&P 500, Nasdaq Dip on Tech Slide

Dow Closes at Record in After-Hours as S&P 500, Nasdaq Dip on Tech Slide

17 June 2026
Dow hits second straight record close at 51,999.67 while S&P 500 and Nasdaq drop as tech stocks slide; Philadelphia semiconductor index plunges 5.7% and after-hours trading sees only slight gains for major index-tracking funds, as investors brace for Wednesday’s Fed decision and monitor inflation risks amid falling oil prices and a possible U.S.-Iran deal.
GD Culture shares drop on heavy trading and ongoing buyout uncertainty

GD Culture shares drop on heavy trading and ongoing buyout uncertainty

17 June 2026
GD Culture Group plunged 73.3% to $0.028 after heavy trading, putting fresh pressure on its unresolved, non-binding $10.75-per-share buyout proposal; risks include deal uncertainty, a $300 million share-sale program, and bitcoin-driven balance sheet swings, with no new company updates released Tuesday.
Go toTop